Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-006366
Filing Date
2018-03-21
Accepted
2018-03-20 19:57:51
Documents
14
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ck0001604950-10k_20171231.htm 10-K 2568024
2 EX-23.1 ck0001604950-ex231_453.htm EX-23.1 4429
3 EX-31.1 ck0001604950-ex311_9.htm EX-31.1 18268
4 EX-31.2 ck0001604950-ex312_8.htm EX-31.2 18201
5 EX-32.1 ck0001604950-ex321_7.htm EX-32.1 9196
6 EX-32.2 ck0001604950-ex322_6.htm EX-32.2 8967
7 GRAPHIC g2018032019400720220476.jpg GRAPHIC 26792
8 GRAPHIC g2018032019395467820475.jpg GRAPHIC 67481
9 GRAPHIC g2018032019395445820471.jpg GRAPHIC 34899
10 GRAPHIC g2018032019395444120469.jpg GRAPHIC 16390
11 GRAPHIC g2018032019395467320474.jpg GRAPHIC 75537
12 GRAPHIC g2018032019395447120473.jpg GRAPHIC 24091
13 GRAPHIC g2018032019395444420470.jpg GRAPHIC 16078
14 GRAPHIC g2018032019395446220472.jpg GRAPHIC 57912
  Complete submission text file 0001564590-18-006366.txt   3067643
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38293 | Film No.: 18703141
SIC: 2834 Pharmaceutical Preparations